The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Markers of sensitivity or resistance to tyrosine kinase inhibitors (TKIs) in NSCLC patients harboring wild type EGFR.
Paola Ulivi
No relevant relationships to disclose
Elisa Chiadini
No relevant relationships to disclose
Alessandra Dubini
No relevant relationships to disclose
Maurizio Puccetti
No relevant relationships to disclose
Marco Angelo Burgio
No relevant relationships to disclose
Angelo Delmonte
No relevant relationships to disclose
Alberto Verlicchi
No relevant relationships to disclose
Alessandro Gamboni
No relevant relationships to disclose
Maximilian Papi
No relevant relationships to disclose
Giovenzio Genestreti
No relevant relationships to disclose
Wainer Zoli
No relevant relationships to disclose
Lucio Crino
No relevant relationships to disclose
Claudio Dazzi
No relevant relationships to disclose